Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

By Hao Yin, Chun‐Qing Song, J. R. Dorkin, Lihua Julie Zhu, Yingxiang Li, Qiongqiong Wu, Angela I. Park, Jung H. Yang, Sneha Suresh, Aizhan Bizhanova and 12 more. Nature Biotechnology, 2016

823 citations recorded by the source corpus.

The combination of Cas9, guide RNA and repair template DNA can induce precise gene editing and the correction of genetic diseases in adult mammals. However, clinical implementation of this technology requires safe and effective delivery of all of these components into the nuclei of the target tissue. Here, we combine lipid nanoparticle–mediated delivery of Cas9 mRNA with adeno-associated viruses encoding a sgRNA and a repair template to induce repair of a disease gene in adult animals. We applied our delivery strategy to a mouse model of human hereditary tyrosinemia and show that the treatment generated fumarylacetoacetate hydrolase (Fah)-positive hepatocytes by correcting the causative Fah-splicing mutation. Treatment rescued disease symptoms such as weight loss and liver damage. The efficiency of correction was >6% of hepatocytes after a single application, suggesting potential utility of Cas9-based therapeutic genome editing for a range of diseases.

Subfields: Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/1129d2a7b8019bb5cab4883aafd21f085b1062ba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. Jerilyn A. Timlin
  2. J. Carney
  3. J. C. Harper
  4. Christopher A. Lino

Citations in the corpus